Ticker
IVVDCompany Name
INVIVYD INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -106.81M | -231.15% | $ 46.21M |
3/31/2025 | $ -139.39M | -379.94% | $ 36.69M |
12/31/2024 | $ -166.81M | -657.15% | $ 25.38M |
9/30/2024 | $ -223.02M | -1928.6% | $ 11.56M |
6/30/2024 | $ -201.78M | -8912.32% | $ 2.26M |
3/31/2024 | $ -204.76M | 0% | $ 0 |
12/31/2023 | $ -196.62M | 0% | $ 0 |
9/30/2023 | $ -167.84M | 0% | $ 0 |
6/30/2023 | $ -173.96M | 0% | $ 0 |
3/31/2023 | $ -175.09M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for INVIVYD INC is calculated as follows: EBITDA [ $ -148.69M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]
Minimum
Jun 30, 2024
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.89% |